Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease (Q46843859)

25 December 2017

title

Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease (English)

1 reference

25 December 2017

author name string

Fang B

1

1 reference

25 December 2017

Song Y

2

1 reference

25 December 2017

Liao L

3

1 reference

25 December 2017

Zhang Y

4

1 reference

25 December 2017

Zhao RC

5

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

25 December 2017

Transplantation Proceedings

published in

1 reference

25 December 2017

volume

39

1 reference

25 December 2017

page(s)

3358-3362

1 reference

25 December 2017

issue

10

1 reference

25 December 2017

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

How I treat chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

RETRACTED: Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Isolation and identification of mesenchymal stem cells from human fetal pancreas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Mesenchymal stem cells in immunoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.08.103

10.1016/J.TRANSPROCEED.2007.08.103

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

release_nsy5knxf45a4vkqjmw2r7a5lv4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nsy5knxf45a4vkqjmw2r7a5lv4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18089385

1 reference

25 December 2017